Post-approval studies (Phase 4)Study completedNCT00650429
What this trial is testing
The Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Who this might be right for
SchizophreniaSchizoaffective Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 28